Business Wire

Pantheon expands international private wealth offerings with evergreen private credit secondary fund

Share

Pantheon, a leading global private markets investor, today announced that it has successfully launched the Pantheon Global Credit Secondaries Fund (PGCS)1, the latest, and seventh, addition to the firm’s growing private wealth platform. PGCS is an evergreen, semi-liquid fund which will be anchored in private credit secondaries — providing international investors with access to transactions completed by Pantheon’s global private credit platform through a single investment. PGCS will have a quarterly liquidity mechanism and will soon be available in 20+ countries across EMEA, Latin America, APAC, and Australia.

PGCS aims to offer investors attractive absolute and risk-adjusted returns by building a diversified portfolio of seasoned, funded, and performing private credit, primarily acquired via LP interests and GP liquidity solutions. The Fund will invest in direct lending strategies and opportunistic credit strategies, aiming to deliver a compelling combination of yield and compounding. Leveraging over three decades of expertise in evergreen product structuring, Pantheon is focused on meeting the complex needs of private wealth investors seeking diversified portfolios and access to exclusive market segments.

Pantheon’s diverse global private wealth platform

The fund launch builds on the momentum and success of Pantheon’s $10.6bn2 global private wealth platform, which has a 38-year track record of providing individual investors access to private markets investing. Pantheon is differentiated within the industry by the breadth of its evergreen fund solutions, which offer investors access to key asset classes through a range of US, UK and International evergreen fund solutions3. This includes the AMG Pantheon Fund (P-PEXX), one of the largest and most established registered private equity funds in the US with approximately $4.7bn4 in assets under management, and the newly-launched private credit secondaries-focused evergreen fund, the AMG Pantheon Credit Solutions Fund (P-SECC). Along with the two established US vehicles, and Pantheon’s broader International Private Wealth platform — which includes the Pantheon Global Private Equity (PGPE) Fund — Pantheon also manages two UK-listed investment trusts, Pantheon International Plc (PIP) and Pantheon Infrastructure Plc (PINT).

Pantheon’s expertise in private credit secondaries strategies

Pantheon has been at the forefront of private credit secondaries since launching the market’s first dedicated fund in 2018. Since that time, the firm has committed approximately $7.9 billion5 to private credit secondaries transactions and has raised over $10.1 billion6 from a range of institutional and private wealth investors7. Most recently, Pantheon’s third senior credit secondaries program (PSD III) closed at $5.2bn, consisting of closed-end co-mingled funds, evergreen and rated insurance vehicles, and separately managed accounts.

Currently, Pantheon’s investment vehicles provide exposure to more than 90 private credit GPs and approximately 5,400 companies worldwide6. Pantheon’s dedicated private credit team has a proven track record of sourcing and managing high-quality secondary investments, providing strong risk management and generating attractive performance8. The firm’s comprehensive private credit strategies invest across the entire credit spectrum, providing clients with diversified access to the asset class and a range of investment solutions.

Rakesh (Rick) Jain, Portfolio Manager and Global Head of Private Credit, commented, “We are proud to be a leading provider of private credit secondaries solutions offerings to our clients globally. We bring significant scale in both capital and transaction experience and a strong partnership approach with both LPs and GPs.”

Toni Vainio, Portfolio Manager and Head of European Private Credit, commented, “We are pleased to provide an attractive access point for diversified global credit secondaries, a growing and attractive sub-segment of the secondaries market, to investors in the international wealth channel.”

Victor Mayer, Head of International Private Wealth said, “Building on PGPE's international success, we're excited to extend Pantheon's specialized semi-liquid expertise into private credit secondaries. Allowing our investors to seek compelling returns and income amid rate fluctuations and persistent inflation — providing international clients with access to the fast-growing credit secondaries market at an enticing time of development.”

About Pantheon

Pantheon* has been at the forefront of private markets investing for more than 40 years, earning a reputation for providing innovative solutions covering the full lifecycle of investments, from primary fund commitments to co-investments and secondary purchases, across private equity, private credit, infrastructure, and real assets.

We have partnered with more than 650 clients, including institutional investors of all sizes as well as a growing number of private wealth advisers and investors, with approximately $70.8bn in discretionary assets under management (as of September 30, 2024).

Leveraging our specialized experience and global team of professionals across Europe, the Americas and Asia, we invest with purpose and lead with expertise to build secure financial futures.

* Pantheon refers to the subsidiaries and subsidiary undertakings of Pantheon Ventures Inc. and AMG Plymouth UK Holdings Limited and includes operating entities principally based in the US (San Francisco and New York), UK (London), Hong Kong, Guernsey, Tokyo, Dublin and Singapore. Pantheon Ventures Inc. and Pantheon Ventures (US) LP are registered as investment advisors with the U.S. Securities and Exchange Commission (“SEC”); Pantheon Securities, LLC is a broker dealer registered with the SEC and is a member of the Financial Industry Regulatory Authority (“FINRA”). Pantheon Ventures (UK) LLP is authorized and regulated by the Financial Conduct Authority (“FCA”) in the United Kingdom. Pantheon Ventures (Guernsey) Ltd and a number of other Pantheon entities incorporated in Guernsey are regulated by the Guernsey Financial Services Commission. Pantheon Ventures (Asia) Limited is registered as a Type II Financial Instruments Business and Investment Advisory and Agency Business Operator with the Kanto Local Finance Bureau in Japan (KLFB). Pantheon Ventures (Ireland) DAC is regulated by the Central Bank of Ireland (“CBI”) and is an appointed representative of Pantheon Ventures (UK) LLP in respect of activities carried out in the United Kingdom. Pantheon Ventures (Singapore) Pte. Ltd holds a capital markets service license from the Monetary Authority of Singapore (“MAS”) to conduct fund management with accredited and institutional investors.

This press release is not an offer of securities for sale. Securities may not be offered or sold in the United States absent registration or an exemption from registration. © 2025

1 For Professional or Qualified Investors only, as applicable. This is a marketing communication, please refer to the Prospectus before making a final investment decision.
2 The NAVs of all underlying private wealth vehicles are as at September 30, 2024, and expressed in US$ terms. Source Pantheon.
3 Pantheon opinion.
4 As of December 31, 2024.
5 Includes all capital committed to credit secondaries investments by Pantheon Private Credit clients from the inception of the private credit program in 2018 through to March 31, 2025.
6 Includes all private credit capital raised for commingled funds, SMAs and evergreen strategies from the formalization of the private credit program through to April 8, 2025.
7 As of January 2025, inclusive of all credit secondaries and co-investments closed from credit secondary-focused commingled funds, SMAs and evergreen vehicles since 2018. In addition, Pantheon has committed $543m to 27 primaries.
8 Pantheon opinion.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250414258316/en/

Contacts

Notes to Editors
For further information, please contact:
Pantheon
Mariella Reason, Pantheon Communications
Tel: +44 20 3473 3975 | Email: mariella.reason@pantheon.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

PCI Pharma Services to Acquire US-based Aseptic Fill-Finish CDMO Ajinomoto Althea24.4.2025 10:00:00 EEST | Press release

PCI Pharma Services (“PCI”) – a leading global contract development and manufacturing organization (CDMO) focused on innovative biopharma therapies – is acquiring an entire equity stake in Ajinomoto Althea, Inc. (“Althea”), a US-based sterile fill-finish CDMO and 100% subsidiary of Japan-based Ajinomoto Co., Inc. Scheduled for completion in May 2025, the acquisition provides PCI with its first-ever North American manufacturing location for prefilled syringes and cartridges – including isolator technology for these formats – as well as high potent manufacturing suitable for antibody-drug conjugates (ADCs). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250424617540/en/ PCI Pharma Services to Acquire US-based Aseptic Fill-Finish CDMO Ajinomoto Althea. Althea’s robust clinical- and commercial-stage services for injectable drug products augments PCI’s deep industry experience, aligning with the company’s global sterile fill-fini

Wolters Kluwer Launches CCH iFirm Personal Tax and CCH iFirm Accounts Production for U.K. Tax and Accounting Professionals24.4.2025 10:00:00 EEST | Press release

Wolters Kluwer Tax and Accounting (TAA) today announced the launch of CCH iFirm Personal Tax and CCH iFirm Accounts Production within its award-winning cloud-based practice management and compliance software platform CCH iFirm® for U.K. professionals. These enhancements deliver seamless, integrated platforms that enhance efficiency, reduce errors, ensure compliance and a more efficient workflow for tax and accounting professionals. Bas Kniphorst, Executive Vice President and Managing Director, Wolters Kluwer TAA Europe said: “These cloud solution modules represent a significant milestone in our commitment to innovation and quality. By providing cutting-edge tools that meet the evolving demands of the tax and accounting industry, we are strengthening our position as a leader in cloud accounting solutions. This not only enhances our product portfolio but also drives growth and reinforces our dedication to delivering exceptional value to our clients. We are confident these launches will e

Jeffrey Lawrence Appointed Chairman of Joe & the Juice24.4.2025 10:00:00 EEST | Press release

Joe & the Juice (“the Company”), an urban juice bar and coffee concept selling freshly prepared juices, coffee, sandwiches and more, today announced that Jeffrey Lawrence, a member of the Company’s Board of Directors since April 2024, has been appointed as Chairman of the Board. Thomas Nørøxe, Chief Executive Officer of Joe & the Juice, said, “Jeff’s elevation to Chairman of Joe & the Juice reflects how his active participation has made a material difference to the Company’s performance and strategy. Over the past year, Joe & the Juice has achieved continued impressive same store sales and revenue growth as we also opened our 400th unit globally. Unit economics remain incredibly strong and digital sales are now nearing 40%. Jeff’s experience will be vital as we continue to expand globally through both company-owned and franchise openings.” Jeffrey Lawrence commented, “Joe & the Juice continues to represent one of the most exciting and dynamic restaurant brands, with true global consume

Manhattan Associates Wins Google Cloud Business Applications Partner of the Year Award for Supply Chain and Logistics24.4.2025 10:00:00 EEST | Press release

Manhattan Associates Inc. (NASDAQ: MANH) today announced that it has received the 2025 Google Cloud Business Applications Partner of the Year Award for Supply Chain and Logistics. This prestigious award highlights Manhattan’s role as an innovator within the Google Cloud ecosystem, its commitment to driving customer success, and its pioneering application of Agentic AI and Generative AI (GenAI) within the Manhattan Active® Suite over the past year. “Google Cloud’s Partner Awards recognize partners who have created outsized value for customers through the delivery of innovative solutions and a high level of expertise,” said Kevin Ichhpurani, President, Global Partner Ecosystem, Google Cloud. "We're proud to announce Manhattan Associates as a 2025 Google Cloud Partner Award winner and celebrate their impact enabling customer success over the past year." “We are honored to be recognized as Google Cloud’s 2025 Business Applications Partner of the Year Award for Supply Chain and Logistics,”

Debiopharm and Oncodesign Services Launch Strategic Collaboration to Propel Radiopharmaceuticals in Preclinical Research24.4.2025 10:00:00 EEST | Press release

Debiopharm Research & Manufacturing S.A. (Debiopharm, www.debiopharm.com), a Swiss-based global biopharmaceutical company aiming to cure cancer and infectious diseases, and Oncodesign Services (www.oncodesign-services.com), a leading CRO specialized in drug discovery and preclinical services, announce the execution of a license agreement for the use of the AbYlink™ technology for preclinical services. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250424538240/en/ AbYlink™ is a regio-selective bioconjugation technology ideally suited for preparing conjugates for use in therapeutic and non-invasive diagnostic applications. Oncodesign Services will use this cutting-edge technology to prepare antibody chelator conjugates for use in preclinical studies to gain insights into the predictive effectiveness of novel treatment approaches in Molecular Radiotherapy, and particularly Radioimmunotherapy in the context of cancer. A joint p

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye